Андрология и генитальная хирургия. 2016; 17: 38-43
Хирургическое лечение больных опухолями надпочечников
https://doi.org/10.17650/2070-9781-2016-17-4-38-43Аннотация
Для оценки характера поражения надпочечников применяют компьютерную томографию, магнитно-резонансную томографию, позитронно-эмиссионную томографию, совмещенную с компьютерной томографией с 18F-фтордезоксиглюкозой, в некоторых случаях используют сцинтиграфию 123I метайодбензилгуанидином. Злокачественные опухоли надпочечников, такие как адренокортикальный рак и злокачественная феохромоцитома, имеют особо агрессивное течение, обусловливающее высокую летальность у данной категории пациентов, особенно на поздних стадиях заболевания. В связи с этим существует статистически значимая разница в выживаемости больных в зависимости от сроков выявления заболевания и начала терапии. В статье представлен анализ результатов хирургического лечения пациентов с опухолями надпочечников.
Список литературы
1. Young W. F. Jr. Clinical practice. The incidentally discovered adrenal mass. New Engl J Med 2007;356:601–10.
2. Kassi E., Kaltsas G., Zografos G. N., Chrousos G. Current issues in the diagnosis and management of adrenocortical carcinomas. Expert Rev Endocrinol Metab 2010;5:451–66.
3. Barzon L., Sonino N., Fallo F. et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003:149:273–85.
4. Kloos R. T., Gross M. D., Francis I. R. et al. Incidentally discovered adrenal masses. Endocr Rev 1995:16:460–84.
5. Mansmann G., Lau J., Balk E. et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004:25:309–40.
6. Fassnacht M., Libé R., Kroiss M. et al. Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol 2011;7(6):323–35. DOI: 10.1038/nrendo. 2010.235.
7. Pacak K., Eisenhofer G., Ahlman H. et al. International symposium on pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the first international symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007;3(2):92–102.
8. Каприн А. Д., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2014 году. М., 2016. 250 с. [Kaprin A. D., Starinskiy V. V., Petrova G. V. Malignant neoplasms in Russia in 2014. Moscow, 2016. 250 p. (In Russ.)].
9. Icard P., Chapuis Y., Andreassian B. et al. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgeons. Surgery 1992;112:972.
10. Berruti A., Baudin E., Gelderblom H. et al. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7): vii131–8.
11. Дедов И. И., Мельниченко Г. А., Фадеев В. В. Эндокринология. М.: Литтерра, 2015. 412 с. [Dedov I. I., Mel’nichenko G. A., Fadeev V. V. Endocrinology. Moscow: Litterra, 2015. 412 p. (In Russ.)].
12. Markou A., Tsigou K., Papadogias D. et al. A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones (Athens) 2005;4:226–30.
13. Lughezzani G., Sun M., Perrotte P. et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer- staging system: a North American validation. Eur J Cancer 2010;46(4):713–9. DOI: 10.1016/j.ejca.2009.12.007.
14. Allolio B., Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027–37.
15. Кузнецов Н. С., Гончаров Н. П., Кация Г. В. и др. Повышение уровня метилированных производных катехоламинов – патогномоничный лабораторный признак феохромоцитомы. Проблемы эндокринологии 2007;(1):33–6. [Kuznetsov N. S., Goncharov N. P., Katsia G. V. et al. Increase in the level of methylated derivatives of the catecholamines is pathognomonic laboratory sign of pheochromocytoma. Problemy endokrinologii = Problems of Endocrinology 2007;(1):33–6. (In Russ.)].
16. Мельниченко Г. А., Стилиди И. С., Алексеев Б. Я. и др. Федеральные клинические рекомендации по диагностике и лечению адренокортикального рака. Проблемы эндокринологии 2014;(2):51– 67. [Mel’nichenko G. A., Stilidi I. S., Alekseev B. Ya. Federal clinical guidelines for the diagnosis and treatment of adrenocortical cancer. Problemy endokrinologii = Problems of Endocrinology 2014;(2):51–67. (In Russ.)].
17. Kimura N., Watanabe T., Noshiro T. et al. Histological grading of adrenal and extraadrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005; Spring16(1):23–32.
18. Weiss L. M. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163–9.
19. van Slooten H., Schaberg A., Smeenk D., Moolenaar A. J. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985;55: 766–73.
20. Aubert S., Wacrenier A., Leroy X. et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 2002;26(12):1612–9.
21. Van’t Sant H. P., Bouvy N. D., Kazemier G. et al. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas. Histopathology 2007;51(2):239–45.
22. Zografos G. N., Kothonidis K., Ageli C. et al. Laparoscopic resection of large adrenal ganglioneuroma. JSLS 2007;11: 487–92.
23. Miller B. S., Gauger P. G., Hammer G. D., Doherty G. M. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 2012;152(6):1150–7. DOI: 10.1016/j. surg. 2012.08.024.
24. Cooper A. B., Habra M. A., Grubbs E. G. et al. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc 2013;27(11):4026–32. DOI: 10.1007/s00464-013-3034-0.
25. Zeiger M., Thompson G., Duh Q.-Y. et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas. Endocr Pract 2009; 15(Suppl 1):1–20.
Andrology and Genital Surgery. 2016; 17: 38-43
Surgical treatment of adrenal tumors
https://doi.org/10.17650/2070-9781-2016-17-4-38-43Abstract
The following methods are usually used for evaluation of adrenal lesion: computed tomography, magnetic resonance imaging, 18F-fluorodeoxyglucose positron emission tomography/computed tomography and sometimes 123I-meta-iodobenzylguanidine scintigraphy. Malignant adrenal tumors, such as adrenocortical carcinoma and malignant pheochromocytoma, appear to have particularly aggressive course, which leads to high mortality rate among these patients, especially in the later stages of the disease. Thus, there is a statistically significant difference in patients’ survival depending on time to diagnosis and time to therapy initiation. In this article we analyze the results of surgical treatment in patients with adrenal tumors
References
1. Young W. F. Jr. Clinical practice. The incidentally discovered adrenal mass. New Engl J Med 2007;356:601–10.
2. Kassi E., Kaltsas G., Zografos G. N., Chrousos G. Current issues in the diagnosis and management of adrenocortical carcinomas. Expert Rev Endocrinol Metab 2010;5:451–66.
3. Barzon L., Sonino N., Fallo F. et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003:149:273–85.
4. Kloos R. T., Gross M. D., Francis I. R. et al. Incidentally discovered adrenal masses. Endocr Rev 1995:16:460–84.
5. Mansmann G., Lau J., Balk E. et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004:25:309–40.
6. Fassnacht M., Libé R., Kroiss M. et al. Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol 2011;7(6):323–35. DOI: 10.1038/nrendo. 2010.235.
7. Pacak K., Eisenhofer G., Ahlman H. et al. International symposium on pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the first international symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007;3(2):92–102.
8. Kaprin A. D., Starinskii V. V., Petrova G. V. Zlokachestvennye novoobrazovaniya v Rossii v 2014 godu. M., 2016. 250 s. [Kaprin A. D., Starinskiy V. V., Petrova G. V. Malignant neoplasms in Russia in 2014. Moscow, 2016. 250 p. (In Russ.)].
9. Icard P., Chapuis Y., Andreassian B. et al. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgeons. Surgery 1992;112:972.
10. Berruti A., Baudin E., Gelderblom H. et al. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7): vii131–8.
11. Dedov I. I., Mel'nichenko G. A., Fadeev V. V. Endokrinologiya. M.: Litterra, 2015. 412 s. [Dedov I. I., Mel’nichenko G. A., Fadeev V. V. Endocrinology. Moscow: Litterra, 2015. 412 p. (In Russ.)].
12. Markou A., Tsigou K., Papadogias D. et al. A unique case of a benign adrenocortical tumor with triple secretion of cortisol, androgens, and aldosterone: development of multiple sclerosis after surgical removal of the tumor. Hormones (Athens) 2005;4:226–30.
13. Lughezzani G., Sun M., Perrotte P. et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer- staging system: a North American validation. Eur J Cancer 2010;46(4):713–9. DOI: 10.1016/j.ejca.2009.12.007.
14. Allolio B., Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027–37.
15. Kuznetsov N. S., Goncharov N. P., Katsiya G. V. i dr. Povyshenie urovnya metilirovannykh proizvodnykh katekholaminov – patognomonichnyi laboratornyi priznak feokhromotsitomy. Problemy endokrinologii 2007;(1):33–6. [Kuznetsov N. S., Goncharov N. P., Katsia G. V. et al. Increase in the level of methylated derivatives of the catecholamines is pathognomonic laboratory sign of pheochromocytoma. Problemy endokrinologii = Problems of Endocrinology 2007;(1):33–6. (In Russ.)].
16. Mel'nichenko G. A., Stilidi I. S., Alekseev B. Ya. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu adrenokortikal'nogo raka. Problemy endokrinologii 2014;(2):51– 67. [Mel’nichenko G. A., Stilidi I. S., Alekseev B. Ya. Federal clinical guidelines for the diagnosis and treatment of adrenocortical cancer. Problemy endokrinologii = Problems of Endocrinology 2014;(2):51–67. (In Russ.)].
17. Kimura N., Watanabe T., Noshiro T. et al. Histological grading of adrenal and extraadrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 2005; Spring16(1):23–32.
18. Weiss L. M. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163–9.
19. van Slooten H., Schaberg A., Smeenk D., Moolenaar A. J. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer 1985;55: 766–73.
20. Aubert S., Wacrenier A., Leroy X. et al. Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 2002;26(12):1612–9.
21. Van’t Sant H. P., Bouvy N. D., Kazemier G. et al. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas. Histopathology 2007;51(2):239–45.
22. Zografos G. N., Kothonidis K., Ageli C. et al. Laparoscopic resection of large adrenal ganglioneuroma. JSLS 2007;11: 487–92.
23. Miller B. S., Gauger P. G., Hammer G. D., Doherty G. M. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery 2012;152(6):1150–7. DOI: 10.1016/j. surg. 2012.08.024.
24. Cooper A. B., Habra M. A., Grubbs E. G. et al. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc 2013;27(11):4026–32. DOI: 10.1007/s00464-013-3034-0.
25. Zeiger M., Thompson G., Duh Q.-Y. et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas. Endocr Pract 2009; 15(Suppl 1):1–20.
